We are live on ! Find out more
OMGA

Omega Therapeutics, Inc. Common Stock

Delisted

OMGA was delisted on the 24th of February, 2025.

43 hedge funds and large institutions have $773M invested in Omega Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+43
Holders Change %
% of All Funds
0.75%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.09%
New
43
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

OMGA Hedge Fund Activity: Q3 2021 in Review

43 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q3 2021, worth a combined $773M.

Buyers outnumbered sellers: 43 funds opened new OMGA positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Flagship Pioneering, opening a new position worth an estimated $497M.

  • 43 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $773M of Omega Therapeutics, Inc. Common Stock stock for Q3 2021.
  • 43 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q3 2021 and 0 closed out, a net change of +43 holders.
  • The largest Omega Therapeutics, Inc. Common Stock buyer in Q3 2021 was Flagship Pioneering, an estimated $497M added.

Based on aggregated 13F filings for Q3 2021.